What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs
Takeda is about to buy its way to a number 1 spot in the top tier of drugmakers fielding the most expensive drugs on the planet.
Once its $62 billion Shire buyout goes through, Takeda will be responsible for selling three of the most expensive drugs on the market today, according to the latest list from GoodRx. And that’s more than any other manufacturer on the ranking.
The drug pricing analysts at GoodRx decided this year that they needed to double the number of drugs tracked in order to be able to fully capture the growing ranks of therapies that command wholesale prices of more than $25,000 a month.
Basic subscription required
Unlock this story instantly and join 53,500+ biopharma pros reading Endpoints daily — and it's free.